气道清除设备市场、机会、成长动力、产业趋势分析与预测，2024-2032

Airway Clearance Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月02日 | 出版商:

Global Market Insights Inc. | 英文 238 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球气道清除设备市场价值为6.462亿美元，到2032年将超过10亿美元，2024年至2032年的复合年增长率为5.1%。病率不断增加，显着推动了气道清除设备市场的成长。此外，改善医疗基础设施还可以透过增加先进医疗设备和治疗方案的取得来促进市场扩张。需要呼吸支持的患者人数不断增长，加上医疗保健设施的不断发展，将显着扩大气道清除设备的市场规模。

气道清除设备市场根据设备类型、应用、最终用途和地区进行划分。

由于振盪呼气正压 (OPEP) 领域在管理慢性呼吸系统疾病方面的有效性，到 2032 年，其复合年增长率将达到 5.5%。 OPEP 设备利用振盪压力帮助清除气道中的黏液，改善肺功能和患者预后。它们经过验证的优点、易用性以及在临床和家庭环境中越来越多的采用使其占据主导地位。随着对有效呼吸疗法的认识和需求的上升，OPEP 细分市场将引领市场。

由于慢性阻塞性肺病 (COPD) 的高盛行率和严重程度，到 2032 年，该领域的市场规模将扩大到 4.223 亿美元。慢性阻塞性肺病患者通常需要专门的设备来管理他们的症状并改善他们的生活品质。慢性阻塞性肺病发病率的增加，加上气道清除技术的进步，推动了对有效管理解决方案的需求。随着人们对慢性阻塞性肺病 (COPD) 认识的提高和治疗选择的扩大，该细分市场将主导市场，反映出其在呼吸护理中的关键作用。

由于先进的医疗基础设施和呼吸道疾病的高发病率，北美气道清除设备产业在 2023 年创造了 2.556 亿美元的收入。该地区受益于对医疗技术的大量投资以及支持采用创新气道清理解决方案的完善的医疗保健系统。此外，旨在管理慢性呼吸道疾病的意识的提高和医疗保健倡议进一步促进了市场成长。北美强大的医疗保健环境使其成为气道清除设备市场的关键贡献者。

产业生态系统分析
产业影响力
- 成长动力
  - 呼吸系统疾病发生率上升
  - 不断提高的患者意识和产品发布
  - 越来越多采用非侵入性治疗方案
  - 政府控制呼吸系统疾病的措施激增
- 产业陷阱与挑战
  - 设备成本高、监管要求严格
成长潜力分析
监管环境
报销场景
技术景观
应用潜力
倡议/政策环境
差距分析
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按设备类型，2021 - 2032 年

主要趋势
振盪呼气正压 (OPEP)
高频胸壁振盪 (HFCWO)
肺内叩击通气 (IPV)
其他设备类型

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
慢性阻塞性肺病（COPD）
支气管扩张
囊肿纤维化
神经肌肉
其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
家庭护理设置
医院
其他最终用户

第 8 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

ABM Respiratory Care
Dymedso Inc.
Electromed Inc.
Hill-Rom Holdings, Inc./Baxter International
ICU Medical
Koninklijke Philips NV
Mercury Medical
Monaghan Medical Corporation
Pari Medical Holding GmbH
Pneumo Care Health Private Limited.
Tactile Medical
Thayer Medical
VORTRAN Medical Technology 1 Inc.
Vyaire Medical, Inc.

简介目录

Product Code: 5820

The Global Airway Clearance Devices Market was valued at USD 646.2 million in 2023 and will exceed USD 1 billion by 2032, with a 5.1% CAGR from 2024 to 2032. The increasing prevalence of respiratory diseases, such as COPD and asthma, is significantly driving the growth of the industry, as these conditions create a heightened demand for effective management solutions. Also, improving healthcare infrastructure is contributing to market expansion by enhancing access to advanced medical devices and treatment options. The combination of a growing patient population requiring respiratory support and the development of better healthcare facilities will boost the market size for airway clearance devices significantly.

The airway clearance devices market is divided based on device type, application, end use , and region.

The oscillatory positive expiratory pressure (OPEP) segment will secure 5.5% CAGR through 2032 due to its effectiveness in managing chronic respiratory conditions. OPEP devices utilize oscillatory pressure to help clear mucus from the airways, improving lung function and patient outcomes. Their proven benefits, ease of use, and increasing adoption in both clinical and home settings contribute to their dominance. As awareness and demand for effective respiratory therapies rise, the OPEP segment will lead the market.

The chronic obstructive pulmonary disease (COPD) segment will expand to USD 422.3 million in 2032, owing to the high prevalence and severity of this condition. COPD patients often require specialized devices to manage their symptoms and improve their quality of life. The increasing incidence of COPD, combined with advancements in airway clearance technologies, drives demand for effective management solutions. As awareness of COPD grows and treatment options expand, this segment will dominate the market, reflecting its critical role in respiratory care.

North America airway clearance devices industry generated revenue of USD 255.6 million in 2023, fueled by its advanced healthcare infrastructure and high prevalence of respiratory diseases. The region benefits from significant investments in medical technology and a well-established healthcare system that supports the adoption of innovative airway clearance solutions. Additionally, increasing awareness and healthcare initiatives aimed at managing chronic respiratory conditions further boost market growth. North America's robust healthcare environment makes it a key contributor to the airway clearance devices market.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rise in incidence of respiratory conditions
  - 3.2.1.2 Growing patient awareness and product launches
  - 3.2.1.3 Increasing adoption of non-invasive treatment options
  - 3.2.1.4 Surge in government initiatives towards controlling respiratory disorders
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High device cost and stringent regulatory requirements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technological landscape
3.7 Application potential
3.8 Initiatives/policy landscape
3.9 Gap analysis
3.10 Future market trends
3.11 Porter's analysis
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn and Units)

5.1 Key trends
5.2 Oscillatory positive expiratory pressure (OPEP)
5.3 High frequency chest wall oscillation (HFCWO)
5.4 Intrapulmonary percussive ventilation (IPV)
5.5 Other device types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Chronic obstructive pulmonary disease (COPD)
6.3 Bronchiectasis
6.4 Cystic fibrosis
6.5 Neuromuscular
6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Home care settings
7.3 Hospitals
7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa